Attached files
| file | filename |
|---|---|
| EX-10.28.2 - EX-10.28.2 - ALBIREO PHARMA, INC. | albo-ex10282_501.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20161231.htm |
| EX-32.1 - EX-32.1 - ALBIREO PHARMA, INC. | albo-ex321_561.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_562.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_530.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | albo-ex231_541.htm |
| EX-10.28.3 - EX-10.28.3 - ALBIREO PHARMA, INC. | albo-ex10283_502.htm |
| EX-10.28.1 - EX-10.28.1 - ALBIREO PHARMA, INC. | albo-ex10281_503.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements of Albireo Pharma, Inc.:
|
(1) |
Registration Statement (Form S-8 No. 333-144407) pertaining to the 2005 Employee Stock Purchase Plan, 2004 Stock Incentive Plan and 2005 Non-Employee Directors’ Stock Option Plan; |
|
(2) |
Registration Statement (Form S-8 No. 333-168903) pertaining to the Amended and Restated 2010 Stock Incentive Plan; |
|
(3) |
Registration Statement (Form S-8 No. 333-180409) pertaining to the Amended and Restated 2010 Stock Incentive Plan; |
|
(4) |
Registration Statement (Form S-3 No. 333-182877); |
|
(5) |
Registration Statement (Form S-3 No. 333-215263); and |
|
(6) |
Registration Statement (Form S-8 No. 333-215264) pertaining to the 2016 Equity Incentive Plan and the Amended and Restated 2010 Stock Incentive Plan; |
of our report dated March 27, 2017, with respect to the consolidated financial statements of Albireo Pharma, Inc. included in this Annual Report (Form 10-K) of Albireo Pharma, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 27, 2017